Roy Eldor

Dr. Eldor serves as Chief Medical Advisor of Oramed Pharmaceuticals, which he joined in 2016.

Dr. Eldor is an endocrinologist, internist, and researcher and is currently Director of the Diabetes Unit at the Institute of Endocrinology, Metabolism & Hypertension, Tel-Aviv Sourasky Medical Center.

He previously served as Principal Scientist at Merck Research Laboratories, Clinical Research – Diabetes & Endocrinology. Prior to that, he served as a senior physician in internal medicine at the Diabetes Unit in Hadassah Hebrew University Hospital, Jerusalem, Israel, and the Diabetes Division at the University of Texas Health Science Center in San Antonio.